These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32768954)

  • 1. Pharmacokinetic behavior of peramivir in the plasma and lungs of rats after trans-nasal aerosol inhalation and intravenous injection.
    Ding H; Wu S; Dai X; Gao Y; Niu Y; Fang N; Song Y; Zhang M; Wang X; Chen T; Zhang G; Wu J; Li Y; Han J
    Biomed Pharmacother; 2020 Sep; 129():110464. PubMed ID: 32768954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and safety of intravenous peramivir, neuraminidase inhibitor of influenza virus, in healthy Japanese subjects.
    Saisho Y; Ishibashi T; Fukuyama H; Fukase H; Shimada J
    Antivir Ther; 2017; 22(4):313-323. PubMed ID: 27805571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection.
    Sugaya N; Kohno S; Ishibashi T; Wajima T; Takahashi T
    Antimicrob Agents Chemother; 2012 Jan; 56(1):369-77. PubMed ID: 22024821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peramivir pharmacokinetics in two critically ill adults with 2009 H1N1 influenza A concurrently receiving continuous renal replacement therapy.
    Bazan JA; Bauer KA; Hollister AS; Shidham G; Firstenberg MS; Reed EE; Mangino JE; Goff DA
    Pharmacotherapy; 2010 Oct; 30(10):1016-20. PubMed ID: 20874039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza viral load and peramivir kinetics after single administration and proposal of regimens for peramivir administration against resistant variants.
    Sato M; Ito M; Suzuki S; Sakuma H; Takeyama A; Oda S; Watanabe M; Hashimoto K; Miyazaki K; Kawasaki Y; Hosoya M
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1643-9. PubMed ID: 25547357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of peramivir after single intravenous doses in healthy Chinese subjects.
    Zhang D; Du A; Zhang L; Ma J; Meng L; Deng M; Xu J; Liu H
    Xenobiotica; 2015 Mar; 45(3):239-43. PubMed ID: 25231091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic Properties of Peramivir After Single and Multiple Intravenous Infusions in Healthy Chinese Volunteers.
    Zhang M; Wang ZZ; Ni XJ; Li LZ; Zhang YF; Lu HY; Peng H; Huang WC; Shen LF; Xiong LH; Shang DW; Wen YG
    Clin Drug Investig; 2016 Sep; 36(9):705-711. PubMed ID: 27317305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peramivir pharmacokinetics in a patient receiving continuous veno-venous hemodiafiltration during the 2009 H1N1 influenza A pandemic.
    Bentley ML; Hollistera AS; Hansenb AC; Smith JA; Cain JS
    Int J Clin Pharmacol Ther; 2014 Dec; 52(12):1105-11. PubMed ID: 25345428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of delayed treatment of China-made Peramivir with repeated intravenous injections in a mouse influenza model: from clinical experience to basal experiment.
    Li Z; Li R; Li J; Xie H; Hao Y; Du Q; Chen T; Li Y; Chen R; Yang Z; Zhong N
    BMC Infect Dis; 2016 Jul; 16():325. PubMed ID: 27392915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of single intravenous injection of peramivir against influenza B virus infection in ferrets and cynomolgus macaques.
    Kitano M; Itoh Y; Kodama M; Ishigaki H; Nakayama M; Ishida H; Baba K; Noda T; Sato K; Nihashi Y; Kanazu T; Yoshida R; Torii R; Sato A; Ogasawara K
    Antimicrob Agents Chemother; 2011 Nov; 55(11):4961-70. PubMed ID: 21844317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peramivir: an intravenous neuraminidase inhibitor.
    McLaughlin MM; Skoglund EW; Ison MG
    Expert Opin Pharmacother; 2015; 16(12):1889-900. PubMed ID: 26153242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peramivir clearance in continuous renal replacement therapy.
    Thomas B; Hollister AS; Muczynski KA
    Hemodial Int; 2010 Jul; 14(3):339-40. PubMed ID: 20491974
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir. II: a pediatric drug use investigation.
    Komeda T; Ishii S; Itoh Y; Ariyasu Y; Sanekata M; Yoshikawa T; Shimada J
    J Infect Chemother; 2015 Mar; 21(3):194-201. PubMed ID: 25523716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between in vivo antiviral activity and pharmacokinetic parameters of peramivir in influenza virus infection model in mice.
    Kodama M; Yoshida R; Hasegawa T; Izawa M; Kitano M; Baba K; Noshi T; Seki T; Okazaki K; Tsuji M; Kanazu T; Kamimori H; Homma T; Kobayashi M; Sakoda Y; Kida H; Sato A; Yamano Y
    Antiviral Res; 2014 Sep; 109():110-5. PubMed ID: 24997412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment.
    Barroso L; Treanor J; Gubareva L; Hayden FG
    Antivir Ther; 2005; 10(8):901-10. PubMed ID: 16430195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of clinical pharmacology in supporting the emergency use authorization of an unapproved anti-influenza drug, peramivir.
    Arya V; Carter WW; Robertson SM
    Clin Pharmacol Ther; 2010 Nov; 88(5):587-9. PubMed ID: 20959843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of pharmacokinetic interaction between intravenous peramivir and oral oseltamivir or rimantadine in humans.
    Atiee G; Lasseter K; Baughman S; McCullough A; Collis P; Hollister A; Hernandez J
    J Clin Pharmacol; 2012 Sep; 52(9):1410-9. PubMed ID: 21960669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a single intravenous dose of the neuraminidase inhibitor peramivir in the treatment of equine influenza.
    Yamanaka T; Bannai H; Nemoto M; Tsujimura K; Kondo T; Muranaka M; Hobo S; Minamijima YH; Yamada M; Matsumura T
    Vet J; 2012 Aug; 193(2):358-62. PubMed ID: 22326934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing intravenous peramivir with oral oseltamivir for patients with influenza: a meta-analysis of randomized controlled trials.
    Fang YH; Hsu TH; Lin TY; Liu CH; Chou SC; Wu JY; Perng PC
    Expert Rev Anti Infect Ther; 2021 Aug; 19(8):1039-1046. PubMed ID: 33641583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-influenza virus activity of peramivir in mice with single intramuscular injection.
    Bantia S; Arnold CS; Parker CD; Upshaw R; Chand P
    Antiviral Res; 2006 Jan; 69(1):39-45. PubMed ID: 16325932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.